William T. Pappafotopoulos
Chief Executive Officer bij Milton Financial Group
Profiel
William T.
Pappafotopoulos is the founder of Milton Financial Group, which was founded in 1985.
He held the title of President & Chief Executive Officer.
Currently, he is a Vice President at Neurovance, Inc. Mr. Pappafotopoulos has an MBA from Suffolk University and an undergraduate degree from Salem State University.
Actieve functies van William T. Pappafotopoulos
Bedrijven | Functie | Begin |
---|---|---|
Milton Financial Group
Milton Financial Group Miscellaneous Commercial ServicesCommercial Services Milton Financial Group is an accounting, finance, tax, and business management firm. The private company is based in Braintree, MA. The company was founded by William T. Pappafotopoulos. William T. Pappafotopoulos has been the CEO since incorporation. | Chief Executive Officer | 01-01-1985 |
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Eerdere bekende functies van William T. Pappafotopoulos
Bedrijven | Functie | Einde |
---|---|---|
Internal Revenue Service | Corporate Officer/Principal | - |
JOHNSON & JOHNSON | Comptroller/Controller/Auditor | - |
Raytheon Aerospace Co.
Raytheon Aerospace Co. Aerospace & DefenseElectronic Technology Part of AIP LLC, Raytheon Aerospace Co. is a private company that manufactures aerospace equipment. The company is based in Madison, MS. Raytheon Aerospace was acquired by The Veritas Capital Fund LP from Raytheon Co. on June 28, 2001 for $157 million. | Comptroller/Controller/Auditor | - |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Opleiding van William T. Pappafotopoulos
Suffolk University | Masters Business Admin |
Salem State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
JOHNSON & JOHNSON | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Neurovance, Inc.
Neurovance, Inc. Miscellaneous Commercial ServicesCommercial Services Neurovance, Inc. operates as a a biopharmaceutical company. It develops treatments for central nervous system disorders. The company was founded by Anthony McKinney and Franklin P. Bymaster in 2011 and is headquartered in Cambridge, MA. | Commercial Services |
Raytheon Aerospace Co.
Raytheon Aerospace Co. Aerospace & DefenseElectronic Technology Part of AIP LLC, Raytheon Aerospace Co. is a private company that manufactures aerospace equipment. The company is based in Madison, MS. Raytheon Aerospace was acquired by The Veritas Capital Fund LP from Raytheon Co. on June 28, 2001 for $157 million. | Electronic Technology |
Internal Revenue Service | Government |
Euthymics Bioscience, Inc.
Euthymics Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Euthymics Bioscience, Inc. develops a novel medicine for alcohol use disorder (AUD) and smoking cessation. It engages in developing a medicine for central nervous system disorders of significant unmet medical need, including major depressive disorder (MDD) and alcohol use disorder (AUD). The firm provides Amitifadine, an antidepressant for major depressive disorder. The firm focuses on the modulation of neurotransmitters, including serotonin (5-HT), norepinephrine (NE), and dopamine (DA). The company was founded by Anthony A. McKinney and Franklin P. Bymaster in 2009 and is headquartered in Cambridge, MA. | Commercial Services |
Milton Financial Group
Milton Financial Group Miscellaneous Commercial ServicesCommercial Services Milton Financial Group is an accounting, finance, tax, and business management firm. The private company is based in Braintree, MA. The company was founded by William T. Pappafotopoulos. William T. Pappafotopoulos has been the CEO since incorporation. | Commercial Services |